Eulerpool Terminal
The edge that pays for itself.
Current MapLight Therapeutics forecasts and price targets in August 2026
Ø Analyst Price Targets
31.62 USD
+138.10 %
Median
31.62 USD
+138.10 %
Max
35.70 USD
Min
28.28 USD
Last Price
13.28 USD
Buy
9
Hold
1
Sell
0
The average target price for MapLight Therapeutics is 31.62 USD. (+138.10 % above the current price)
The median price target of MapLight Therapeutics is 31.62 USD.
Stock analysts from many renowned investment banks are closely examining the MapLight Therapeutics stock. They conclude their professional MapLight Therapeutics stock analyses with a clear recommendation for the MapLight Therapeutics stock. The forecasts and price targets of professional analysts can be a good indicator of how a stock will perform in the next quarter.
| Buy | Hold | Sell | Ø Analyst Price Targets | |
|---|---|---|---|---|
| 2026-03-01 | 9 | 1 | 0 | — |
| 2026-02-01 | 9 | 1 | 0 | 31.62 USD |
| 2026-02-01 | 9 | 1 | 0 | 31.62 USD |
| 2026-01-01 | 9 | 1 | 0 | 31.62 USD |
| 2025-12-01 | 8 | 1 | 0 | 31.62 USD |
| 2025-12-01 | 8 | 1 | 0 | 31.62 USD |
MapLight Therapeutics Stock Forecast 2026: Revenue & Earnings Estimates
Analysts expect the following revenue and earnings for MapLight Therapeutics in the coming fiscal years:
| Fiscal year | Revenue | Net Income | Earnings per share |
|---|---|---|---|
| 2027e | 18.00 M USD | -172.00 M USD | -3.91 USD |
| 2029e | 24.00 M USD | -176.00 M USD | -4.00 USD |
| 2030e | 88.00 M USD | -154.00 M USD | -3.50 USD |